Location: Home
  • search
  • go
  • Relate News
  • 2/7/2017Survey: 33% of Chinese Pharma Marketers Will Spend 20%+ on Digital Cha...
  • 2/6/2017Mobile Medical Healthcare Trends in China
  • 2/6/2017NHFPC Issues New Policy for Trial of Medical Consortiums
  • 2/3/2017Recent Executive Moves
  • 2/2/2017FirboGen Posts Positive Chinese Phase III Data for AZ-Partnered Anemia...
  • 2/2/2017Wuxi PharmaTechs CMO Subsidiary Expands Facility in Changzhou
  • 2/2/2017Trump Wants Big Pharma Cut Outsourcing and Prices, Promising Loosened ...
  • 2/2/2017Tough and Turbulent Time Ahead in the Coming Year of Trump Rooster - 2...
  • 2/1/2017Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 1/27/2017China Healthcare Investment Cools But Remains Impressive
  • 1/26/20172016 Compliance Enforcement in the Pharmaceutical Industry
  • 1/25/2017China's Fast Growing Life Sciences Sector Prepared to Compete for Expe...
  • 1/25/2017China to Issue A Major Reform Policy Covering Full Process of Drug Ind...
  • 1/24/2017Are Reforms Focused on Pharma Kickbacks in China, the Last Straw to Pu...
  • 1/23/2017Chinese Antibody Drug Developer Mabworks Raises $39M in Series B Round...
  • 1/23/2017China Reduces Import Duties of 22 APIs to Zero
  • 1/23/2017The State Council Withdraws Three Local Pharma Approval Requirements, ...
  • 1/22/2017Legochem Licenses China Right of Novel Antibiotic to RMX Biopharma
  • 1/22/2017WuXi AppTec Acquires CRO HD Biosciences
  • 1/20/2017NHFPC Announces the Outline of Key Health and Family Planning Tasks in...
  • 1/19/2017APR Licenses Greater China Rights of Patented Migraine Drug Formulatio...
  • 1/19/201715 Chinese Biopharma Cos Became Listed on the A Share Stock Market in ...
  • 1/19/2017Recent Executive Moves
  • 1/19/2017Ten Upcoming Trends of the Chinese Pharmaceutical Market in 2017
  • 1/19/2017The Outlook for China in the Global Pharmaceutical Market
  • 1/18/2017WuXi MedImmune Secures CFDA’s Clinical Approval for Phase I of RA Dru...
  • 1/17/2017Hangzhou Minsheng Takes Over Chinese Joint Venture with Sanofi
  • 1/17/2017Eight MNCs Submitted More Than 40 Chinese Drug Application in 2016
  • 1/17/2017Chi-Med Initiates a Phase II Study of Sulfatinib in Second-line Biliar...
  • 1/16/2017Mergermarket: Global Pharma and Biotech M&A Feels the Heat in 2016
  • Page:192/359 Total number of articles:10741: [First][<<] [190] [191] [192] [193] [194] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group